Effect of Iron Deficiency on c-kit+ Cardiac Stem Cells In Vitro
Authors:
Open Access
- 10 June 2013
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 8 (6) , e65721
Abstract
Iron deficiency is a common comorbidity in chronic heart failure (CHF) which may exacerbate CHF. The c-kit+ cardiac stem cells (CSCs) play a vital role in cardiac function repair. However, much is unknown regarding the role of iron deficiency in regulating c-kit+ CSCs function. In this study, we investigated whether iron deficiency regulates c-kit+ CSCs proliferation, migration, apoptosis, and differentiation in vitro. All c-kit+ CSCs were isolated from adult C57BL/6 mice. The c-kit+ CSCs were cultured with deferoxamine (DFO, an iron chelator), mimosine (MIM, another iron chelator), or a complex of DFO and iron (Fe(III)), respectively. Cell migration was assayed using a 48-well chamber system. Proliferation, cell cycle, and apoptosis of c-kit+ CSCs were analyzed with BrdU labeling, population doubling time assay, CCK-8 assay, and flow cytometry. Caspase-3 protein level and activity were examined with Western blotting and spectrophotometric detection. The changes in the expression of cardiac-specific proteins (GATA-4,TNI, and β-MHC) and cell cycle-related proteins (cyclin D1, RB, and pRB) were detected with Western blotting. DFO and MIM suppressed c-kit+ CSCs proliferation and differentiation. They also modulated cell cycle and cardiac-specific protein expression. Iron chelators down-regulated the expression and phosphorylation of cell cycle-related proteins. Iron reversed those suppressive effects of DFO. DFO and MIM didn’t affect c-kit+ CSCs migration and apoptosis. Iron deficiency suppressed proliferation and differentiation of c-kit+ CSCs. This may partly explain how iron deficiency affects CHF prognosis.Keywords
This publication has 37 references indexed in Scilit:
- Health Economic Assessment of Ferric Carboxymaltose in Patients with Iron Deficiency and Chronic Heart Failure Based on the FAIR-HF Trial: An Analysis for the UKEuropean Journal of Heart Failure, 2012
- Cellular Iron Depletion and the Mechanisms Involved in the Iron-dependent Regulation of the Growth Arrest and DNA Damage Family of GenesJournal of Biological Chemistry, 2011
- Hypoxia-mimetic agents inhibit proliferation and alter the morphology of human umbilical cord-derived mesenchymal stem cellsBMC Cell Biology, 2011
- Circulating, Imaging, and Genetic Biomarkers in Cardiovascular Risk PredictionTrends in Cardiovascular Medicine, 2011
- Ischaemia/reperfusion induced cardiac stem cell homing to the injured myocardium by stimulating stem cell factor expression via NF‐κB pathwayInternational Journal of Experimental Pathology, 2009
- Prolonged Exposure to LPS Increases Iron, Heme, and p22 phox Levels and NADPH Oxidase Activity in Human Aortic Endothelial CellsArteriosclerosis, Thrombosis, and Vascular Biology, 2009
- Imaging Survival and Function of Transplanted Cardiac Resident Stem CellsJACC, 2009
- ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM)European Heart Journal, 2008
- c-kit Is Required for Cardiomyocyte Terminal DifferentiationCirculation Research, 2008
- Stem cell niches in the adult mouse heartProceedings of the National Academy of Sciences, 2006